Kwon H. Hong, Ph.D. - Publications

2014 Medicinal Chemistry University of Minnesota, Twin Cities, Minneapolis, MN 
Therapeutics Discovery & Development

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ranade AR, Higgins L, Markowski TW, Glaser N, Kashin D, Bai R, Hong KH, Hamel E, Höfle G, Georg GI. Characterizing the Epothilone Binding Site on β-Tubulin by Photoaffinity Labeling: Identification of β-Tubulin Peptides TARGSQQY and TSRGSQQY as Targets of an Epothilone Photoprobe for Polymerized Tubulin. Journal of Medicinal Chemistry. PMID 26986898 DOI: 10.1021/acs.jmedchem.6b00188  0.32
2015 Yune J, Hong KH, Lim HT, Lee JC, Kwon O, Han SW, Kim YS, Moon S, Kim YH. Quantum discord protection from amplitude damping decoherence. Optics Express. 23: 26012-26022. PMID 26480116  0.32
2015 Hong KH, Lee JK, Byun SJ, Jung JW, Han IW, Jung JH, Kim EJ. A Case of Leukemoid Reaction in Pancreatic Ductal Adenocarcinoma. The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi. 66: 116-21. PMID 26289246 DOI: 10.4166/kjg.2015.66.2.116  0.32
2015 Kim CY, Seo SH, An MS, Kim KH, Bae KB, Hwang JW, Kim JH, Kim BM, Kang MS, Oh MK, Hong KH. ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting. Annals of Coloproctology. 31: 92-7. PMID 26161376 DOI: 10.3393/ac.2015.31.3.92  0.32
2015 Cai J, Wei H, Hong KH, Wu X, Zong X, Cao M, Wang P, Li L, Sun C, Chen B, Zhou G, Chen J, Ji M. Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents. Bioorganic & Medicinal Chemistry. 23: 3457-71. PMID 25953722 DOI: 10.1016/j.bmc.2015.04.028  0.32
2015 An MS, Yoo JH, Kim KH, Bae KB, Choi CS, Hwang JW, Kim JH, Kim BM, Kang MS, Oh MK, Hong KH. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy. World Journal of Surgical Oncology. 13: 64. PMID 25889520 DOI: 10.1186/s12957-015-0488-7  0.32
2015 Cai J, Wei H, Hong KH, Wu X, Cao M, Zong X, Li L, Sun C, Chen J, Ji M. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors. European Journal of Medicinal Chemistry. 96: 1-13. PMID 25874326 DOI: 10.1016/j.ejmech.2015.04.002  0.32
2015 Jeong IS, Yoo JH, Seo SH, An MS, Kim KH, Bae KB, Choi CS, Hwang JW, Kim JH, Kang MS, Oh MK, Hong KH. Association Between Time (Initiation and Length) and Oncological Outcomes for the Patients with Colon Cancer Treated with Adjuvant Chemotherapy Indian Journal of Surgery. DOI: 10.1007/s12262-015-1270-3  0.32
2014 Cai J, Li L, Hong KH, Wu X, Chen J, Wang P, Cao M, Zong X, Ji M. Discovery of 4-aminoquinazoline--urea derivatives as Aurora kinase inhibitors with antiproliferative activity. Bioorganic & Medicinal Chemistry. 22: 5813-23. PMID 25270403 DOI: 10.1016/j.bmc.2014.09.029  0.32
2014 Song JM, Qian X, Upadhyayya P, Hong KH, Kassie F. Dimethylaminoparthenolide, a water soluble parthenolide, suppresses lung tumorigenesis through down-regulating the STAT3 signaling pathway. Current Cancer Drug Targets. 14: 59-69. PMID 24200081 DOI: 10.2174/15680096113136660108  0.32
2012 Niphakis MJ, Gay BC, Hong KH, Bleeker NP, Georg GI. Synthesis and evaluation of the anti-proliferative and NF-κB activities of a library of simplified tylophorine analogs. Bioorganic & Medicinal Chemistry. 20: 5893-900. PMID 22910225 DOI: 10.1016/j.bmc.2012.07.044  0.32
Show low-probability matches.